Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jun;64(6):2056–2061. doi: 10.1128/iai.64.6.2056-2061.1996

Conservation of the sporozoite p67 vaccine antigen in cattle-derived Theileria parva stocks with different cross-immunity profiles.

V Nene 1, A Musoke 1, E Gobright 1, S Morzaria 1
PMCID: PMC174036  PMID: 8675307

Abstract

Immunity to Theileria parva infection in cattle is often parasite stock specific. The antigenic diversity which is expressed at the schizont stage of the parasite together with a wild reservoir of the organism in buffalo has complicated the development of effective disease control by immunization. We have previously shown that about 70% of cattle inoculated with recombinant forms of p67, a sporozoite stage-specific surface antigen from the cattle-derived Muguga stock of the parasite, are immune to a homologous challenge. Thus, immune responses to p67 can play a role in immunity. The genes encoding this protein in five other parasite stocks have been sequenced. Here, we report that the p67 molecule encoded by four cattle-derived parasite stocks (Boleni, Uganda, Mariakani, and Marikebuni) that fall into different cross-immunity groups is identical in sequence to Muguga p67. The protein encoded by a buffalo-derived parasite exhibits 95% sequence identity with Muguga p67, the major difference being the presence of a 43-residue peptide insert. As predicted by these data, cattle inoculated with recombinant p67 can resist a heterologous cattle-derived parasite challenge. Seven of 12 cattle receiving a homologous Muguga challenge and 6 of 11 cattle receiving a heterologous Marikebuni challenge were immune to East Coast fever. These results extend earlier data suggesting that p67 is a conserved molecule and confirm its potential as a broad-spectrum vaccine antigen for the control of T. parva infection.

Full Text

The Full Text of this article is available as a PDF (324.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Conrad P. A., Iams K., Brown W. C., Sohanpal B., ole-MoiYoi O. K. DNA probes detect genomic diversity in Theileria parva stocks. Mol Biochem Parasitol. 1987 Oct;25(3):213–226. doi: 10.1016/0166-6851(87)90085-5. [DOI] [PubMed] [Google Scholar]
  2. Dobbelaere D. A., Spooner P. R., Barry W. C., Irvin A. D. Monoclonal antibody neutralizes the sporozoite stage of different Theileria parva stocks. Parasite Immunol. 1984 Jul;6(4):361–370. doi: 10.1111/j.1365-3024.1984.tb00808.x. [DOI] [PubMed] [Google Scholar]
  3. Emery D. L. Adoptive transfer of immunity to infection with Theileria parva (East Coast fever) between cattle twins. Res Vet Sci. 1981 May;30(3):364–367. [PubMed] [Google Scholar]
  4. Irvin A. D., Dobbelaere D. A., Mwamachi D. M., Minami T., Spooner P. R., Ocama J. G. Immunisation against East Coast fever: correlation between monoclonal antibody profiles of Theileria parva stocks and cross immunity in vivo. Res Vet Sci. 1983 Nov;35(3):341–346. [PubMed] [Google Scholar]
  5. Jarrett W. F., Crighton G. W., Pirie H. M. Theileria parva: kinetics of replication. Exp Parasitol. 1969 Feb;24(1):9–25. doi: 10.1016/0014-4894(69)90215-x. [DOI] [PubMed] [Google Scholar]
  6. Katzer F., Carrington M., Knight P., Williamson S., Tait A., Morrison I. W., Hall R. Polymorphism of SPAG-1, a candidate antigen for inclusion in a sub-unit vaccine against Theileria annulata. Mol Biochem Parasitol. 1994 Sep;67(1):1–10. doi: 10.1016/0166-6851(94)90090-6. [DOI] [PubMed] [Google Scholar]
  7. Ling L. L., Keohavong P., Dias C., Thilly W. G. Optimization of the polymerase chain reaction with regard to fidelity: modified T7, Taq, and vent DNA polymerases. PCR Methods Appl. 1991 Aug;1(1):63–69. doi: 10.1101/gr.1.1.63. [DOI] [PubMed] [Google Scholar]
  8. Marchuk D., Drumm M., Saulino A., Collins F. S. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 1991 Mar 11;19(5):1154–1154. doi: 10.1093/nar/19.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McKeever D. J., Taracha E. L., Innes E. L., MacHugh N. D., Awino E., Goddeeris B. M., Morrison W. I. Adoptive transfer of immunity to Theileria parva in the CD8+ fraction of responding efferent lymph. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1959–1963. doi: 10.1073/pnas.91.5.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Minami T., Spooner P. R., Irvin A. D., Ocama J. G., Dobbelaere D. A., Fujinaga T. Characterisation of stocks of Theileria parva by monoclonal antibody profiles. Res Vet Sci. 1983 Nov;35(3):334–340. [PubMed] [Google Scholar]
  11. Morrison W. I., Goddeeris B. M. Cytotoxic T cells in immunity to Theileria parva in cattle. Curr Top Microbiol Immunol. 1990;155:79–93. doi: 10.1007/978-3-642-74983-4_6. [DOI] [PubMed] [Google Scholar]
  12. Morzaria S. P., Spooner P. R., Bishop R. P., Musoke A. J., Young J. R. SfiI and NotI polymorphisms in Theileria stocks detected by pulsed field gel electrophoresis. Mol Biochem Parasitol. 1990 May;40(2):203–211. doi: 10.1016/0166-6851(90)90042-k. [DOI] [PubMed] [Google Scholar]
  13. Musoke A. J., Nantulya V. M., Rurangirwa F. R., Buscher G. Evidence for a common protective antigenic determinant on sporozoites of several Theileria parva strains. Immunology. 1984 Jun;52(2):231–238. [PMC free article] [PubMed] [Google Scholar]
  14. Musoke A. J., Nene V. Development of recombinant antigen vaccines for the control of theileriosis. Parassitologia. 1990 Apr;32(1):73–85. [PubMed] [Google Scholar]
  15. Musoke A., Morzaria S., Nkonge C., Jones E., Nene V. A recombinant sporozoite surface antigen of Theileria parva induces protection in cattle. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):514–518. doi: 10.1073/pnas.89.2.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mutugi J. J., Young A. S., Maritim A. C., Ndungu S. G., Mining S. K., Linyonyi A., Ngumi P. N., Leitch B. L., Morzaria S. P., Dolan T. T. Immunisation of cattle against theileriosis in Coast Province, Kenya: laboratory evaluation of a Theileria parva parva stabilate for use in 'infection and treatment' immunisation in the field. Res Vet Sci. 1989 Sep;47(2):170–177. [PubMed] [Google Scholar]
  17. Nene V., Iams K. P., Gobright E., Musoke A. J. Characterisation of the gene encoding a candidate vaccine antigen of Theileria parva sporozoites. Mol Biochem Parasitol. 1992 Mar;51(1):17–27. doi: 10.1016/0166-6851(92)90196-q. [DOI] [PubMed] [Google Scholar]
  18. Pinder M., Hewett R. S. Monoclonal antibodies detect antigenic diversity in Theileria parva parasites. J Immunol. 1980 Feb;124(2):1000–1001. [PubMed] [Google Scholar]
  19. Tindall K. R., Kunkel T. A. Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry. 1988 Aug 9;27(16):6008–6013. doi: 10.1021/bi00416a027. [DOI] [PubMed] [Google Scholar]
  20. Toye P. G., Goddeeris B. M., Iams K., Musoke A. J., Morrison W. I. Characterization of a polymorphic immunodominant molecule in sporozoites and schizonts of Theileria parva. Parasite Immunol. 1991 Jan;13(1):49–62. doi: 10.1111/j.1365-3024.1991.tb00262.x. [DOI] [PubMed] [Google Scholar]
  21. Uilenberg G., Perié N. M., Lawrence J. A., de Vos A. J., Paling R. W., Spanjer A. A. Causal agents of bovine theileriosis in southern Africa. Trop Anim Health Prod. 1982 Aug;14(3):127–140. doi: 10.1007/BF02242143. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES